| Financial Year |
March 31 2023 |
| Monetary Funds |
341,619,008.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
304,915,181.00 |
| Accounts Receivable |
278,172,340.12 |
| Advances to Suppliers |
14,399,203.44 |
| Other Receivables |
8,396,141.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
333,822,711.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,099,962.87 |
| Total Current Assets |
1,285,632,589.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
255,773,704.37 |
| Under-construction Projects |
3,562,142.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,250,225.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,612,140.68 |
| Deferred Income Tax Assets |
12,993,528.71 |
| Other Non-Current Assets |
6,010,026.30 |
| Sub-Total of Non-Current Assets |
288,201,768.01 |
| Total Assets |
1,573,834,357.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,983,547.50 |
| Accounts Payable |
266,245,732.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,493,575.69 |
| Taxes Payable |
5,932,652.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,116,995.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
139,698.22 |
| Sub-Total of Current Liabilities |
315,281,491.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,046,000.00 |
| Total Liabilities |
316,327,491.53 |
| Paid-In Capital(Or Share Stock) |
180,000,000.00 |
| Capital Surplus |
343,462,191.74 |
| Surplus Reserve |
86,109,895.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
647,934,779.61 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,257,506,866.43 |
| Owner's Equity（Stockholder's Equity） |
1,257,506,866.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,573,834,357.96 |
